1. Pink Sheet
  2. >>Legal & IP
  3. >>Patents

IGBA Picks Apart Innovator Patent ‘Gaming Systems’

A New Report Illustrates Strategies Delaying Or Blocking Off-Patent Competition

 
• By Urtė Fultinavičiūtė

The International Generic and Biosimilar Medicines Association has introduced its first global intellectual property and competition report, addressing the urgent need to reform current regulations. But, in a bid to increase access to medicines across the world, did it stop short at just IP and patents?

Chess figures placed on map with connecting lines between them
The IGBA's report on patent abuse strategies covers multiple regions (Shutterstock)
Key Takeaways
  • A 123-page report from the International Generic and Biosimilar Medicines Association examines patent abuse strategies and highlights the different ways originators try to monopolize markets beyond the intended terms
  • The report analyzes seven evergreening practices: patent thickets, patent linkage, elimination of skinny labels, product hopping, pricing strategies, denigration, and misuse of regulatory procedures.
  • The IGBA highlights the need to reform current laws, regulations and practices, which make patent abuse strategies possible.

The International Generic and Biosimilar Medicines Association (IGBA) has released a first-of-its-kind

Titled ‘Gaming the system: An overview of originator companies’ evergreening strategies used to hinder access to generic and biosimilar products,” the 123-page report highlights the different ways

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Patents

More from Legal & IP